Sio Capital Management, LLC Coherus Bio Sciences, Inc. Transaction History

Sio Capital Management, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$12.68 - $17.79 $5.25 Million - $7.36 Million	-413,733 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$12.95 - $15.41 $5.62 Million - $6.69 Million	-434,129 Reduced 51.2%	413,733 $5.72 Million
Q1 2021 May 14, 2021	SELL	$14.42 - $21.39 $233,517 - $346,389	-16,194 Reduced 1.87%	847,862 $12.4 Million
Q4 2020 Feb 16, 2021	SELL	$16.56 - $18.94 $2.98 Million - $3.41 Million	-180,105 Reduced 17.25%	864,056 $15 Million
Q3 2020 Nov 16, 2020	SELL	$17.41 - $19.89 $1.6 Million - $1.82 Million	-91,702 Reduced 8.07%	1,044,161 $19.2 Million
Q2 2020 Aug 14, 2020	BUY	$14.43 - $19.16 $837,286 - $1.11 Million	58,024 Added 5.38%	1,135,863 $20.3 Million
Q1 2020 May 15, 2020	BUY	$11.67 - $22.53 $1.53 Million - $2.95 Million	131,078 Added 13.84%	1,077,839 $17.5 Million
Q4 2019 Feb 14, 2020	BUY	$16.33 - $21.37 $5.58 Million - $7.31 Million	341,976 Added 56.55%	946,761 $17 Million
Q3 2019 Nov 14, 2019	BUY	$16.3 - $23.37 $6.85 Million - $9.83 Million	420,419 Added 228.03%	604,785 $12.3 Million
Q2 2019 Aug 14, 2019	BUY	$13.1 - $22.1 $2.42 Million - $4.07 Million	184,366 New	184,366 $4.07 Million

143

82.7M

79.1K

100K

Ticker CHRS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,724,600
Market Cap $80.8M
Description
Coherus BioSciences, Inc., a biopharmaceutical company, focuses on the biosimilar and immuno-oncology market primarily in the United States. The company markets UDENYCA, a biosimilar to Neulasta, a long-acting granulocyte stimulating colony factor in the United States. Its pipeline products include biosimilars of Humira, Avastin, and Lucentis. T...

Get notified when there are updates to the investment portfolio of Sio Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Sio Capital Management, LLC with notifications on news.